Dr Sara Ghorashian talks to ecancer at the ALL Assembly 2018 Meeting in Amsterdam about the challenges and opportunities of using CAR-T cells to treat ALL patients.

Dr Ghorashian outlines the three studies that she presented on this treatment.

She explains that expansion cohorts are being developed to create more spaces for patients potentially eligible for this treatment.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.